[1]展玉涛, 魏红山, 王志荣, 等.大黄素抗肝纤维化的实验研究[J].中华肝脏病杂志, 2001, 9 (4) ∶235-239.
|
[2]Friedman SL, Roll FJ.Isolation and culture of hepatic lipocytes, kupffercells, and sinusoidal endothelial cells by density gradient centrifugationwith stractan[J].Anal Biochem, 1987, 161 (1) ∶207-218.
|
[3]展玉涛, 陈颖伟, 卫新革, 等.大黄素对肝纤维化大鼠肝功能的影响[J].实用肝脏病杂志, 1999, 4 (4) ∶196-197.
|
[4]Isono M, Soda M, Inoue A, et al.Reverse transformation of hepatic my-ofibroblast-like cells by TGFbetal/LAP[J].Biochem Biophys Res Com-mun, 2003, 311 (4) ∶959-965.
|
[5] Kauschke SG, Knorr A, Heke M, et al.Two assays for measuring fibro-sis∶reverse transcriptase-polymerase chain reaction of collagen alpha (1) (Ⅲ) mRNA is an early predictor of subsequent collagen depositionwhile a novel serum N-terminal procollagen (Ⅲ) propeptide assay re-flects manifest fibrosis in carbon tetrachloride-treated rats[J].AnalBiochem, 1999, 275 (2) ∶131-140.
|
[1] | Zhiyi WANG, Guangyue YANG, Wei ZHANG, Yaqiong PU, Xin ZHAO, Wenting MA, Xuling LIU, Liu WU, Le TAO, Cheng LIU. Role of podoplanin in hepatic stellate cell activation and liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(3): 533-538. doi: 10.12449/JCH240316 |
[2] | Jun GAO, Huan CHEN, Yan LIU, Feng ZHANG, Yuzheng ZHUGE. Effect of interleukin-22 on hepatic stellate cell activation and its mechanism[J]. Journal of Clinical Hepatology, 2024, 40(11): 2229-2237. doi: 10.12449/JCH241116 |
[3] | Yuxin YAN, Xiaoyang GAO, Chunyan ZHANG, Rong JIN, Hongwei YUAN, Yuehong MA. Role and mechanism of action of the Mongolian medicine Scabiosa atropurea in inhibiting the proliferation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2023, 39(6): 1351-1357. doi: 10.3969/j.issn.1001-5256.2023.06.015 |
[4] | Jing PENG, Wei YUAN, Sihan YIN, Kewei SUN. Mechanism of NLRP3 inflammasome promoting hepatic stellate cell activation[J]. Journal of Clinical Hepatology, 2022, 38(11): 2611-2615. doi: 10.3969/j.issn.1001-5256.2022.11.035 |
[5] | Ning YANG, Jiang DENG, Yikai WANG, Sha CHANG, Ning GAO, Wenjun WANG, Shuangsuo DANG, Juanjuan SHI. Role and mechanism of caffeic acid phenethyl ester in hepatic stellate cell[J]. Journal of Clinical Hepatology, 2022, 38(10): 2273-2278. doi: 10.3969/j.issn.1001-5256.2022.10.014 |
[6] | Tingyu REN, Hezhongrong NIE, Lijia XIAO, Fangnan LIN, Daming WANG, Chunli SONG, Yiwen ZHOU. Effect of hepatitis B x gene-overexpressed hepatocytes on the proliferation and activation of hepatic stellate cells and related mechanism[J]. Journal of Clinical Hepatology, 2021, 37(7): 1561-1566. doi: 10.3969/j.issn.1001-5256.2021.07.017 |
[7] | Wu Jie, Li JingTao, Wei HaiLiang, Yan ShuGuang, Fan Yu, Guo YingJun, Chang ZhanJie. Advances in the role of microRNA in the intervention of malignant transformation of precancerous lesions of the liver by regulating the activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2020, 36(7): 1650-1654. doi: 10.3969/j.issn.1001-5256.2020.07.045 |
[8] | Yang MiaoMiao, Wu ZhiHui, Tu ZhengKun. Hepatitis B virus-mediated interaction between hepatic stellate cells and innate immune cells[J]. Journal of Clinical Hepatology, 2020, 36(4): 891-894. doi: 10.3969/j.issn.1001-5256.2020.04.040 |
[9] | Huang XiaoLi, Liu YingYing, Cong Min. Research advances in drug carrier systems targeting hepatic stellate cells[J]. Journal of Clinical Hepatology, 2020, 36(1): 208-212. doi: 10.3969/j.issn.1001-5256.2020.01.050 |
[10] | Li TianYang, Tu ZhengKun, Su LiShan. Regulatory effect of natural killer cells on hepatic stellate cells and their role in liver fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 558-562. doi: 10.3969/j.issn.1001-5256.2017.03.036 |
[11] | Zhao WeiHua, Wang YanHong, Cong Min. Regulatory effect of transforming growth factor-β on activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(11): 2195-2198. doi: 10.3969/j.issn.1001-5256.2016.11.044 |
[12] | Ren ChangZhen, Hao LiSen. Signal transduction involved in activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2015, 31(3): 452-456. doi: 10.3969/j.issn.1001-5256.2015.03.034 |
[13] | Zhang Zhan, Ping Jian, Xu LieMing. Screening Chinese medicine components for inhibition of human hepatic stellate cell migration[J]. Journal of Clinical Hepatology, 2012, 28(3): 183-188+191. |
[14] | Lu XiaoJu, Chen YongPing, Yang Tao, Cheng Yuan, Jin XiaoZhi, Shen ChunYan, Liu Jun, Wang ChunYing, Wang XiaoDong, Lin Zhuo. The influence of regulatory T cells in hepatic stellate cell proliferation and HA secretion[J]. Journal of Clinical Hepatology, 2012, 28(1): 39-43. |
[15] | Weng ShanGeng, Xu ChangGuo, Sun Ying, Shi Zheng, Lin LiJuan. Study on the apoptosis of rat hepatic stellate cells induced by kapamycin[J]. Journal of Clinical Hepatology, 2012, 28(3): 219-222. |
[16] | Zhang LiLi, Guo XiaoHong, Liu LiXin, Zhang QianQian. IGFBPrP1 siRNA induced apoptosis in rat hepatic stellate cells and its mechanism[J]. Journal of Clinical Hepatology, 2011, 27(9): 965-969+979. |
[17] | Liu LiXin, Qiu ZhiHong, Zhang QianQian. Effects of knocking down IGFBPrP1 with siRNA on extracellular matrix secretion in HSC-T6[J]. Journal of Clinical Hepatology, 2011, 27(3): 248-250. |
[18] | Dai YongMei, Cai LiMian, Lin Leng. The effect of octreotide on the expression of collagen、TIMP-1 and MMP-2 in HSC1[J]. Journal of Clinical Hepatology, 2008, 24(5): 332-334. |
[19] | Yang WeiFeng, Chen HouChang, Li Lin. Effect of Curcumin on proliferation and extracellular matrix secretion of rat hepatic stellate cells in vitro[J]. Journal of Clinical Hepatology, 2004, 20(3): 142-143. |
[20] | Cheng JiLin, Zhou Xin, Li DingGuo, Wei HongShan, Huang Xin, Wang ZhiRong, Zhan YuTao, Zhang Jing, Xu QinFang, Lu HanMing. RGDS peptides inhibit hepatic stellate cells synthesizing extracellular matrix stimulated by transforming growth factor beta.[J]. Journal of Clinical Hepatology, 2001, 17(3): 173-175. |